Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Free Cash Flow: 2017-2024

Historic Free Cash Flow for IDEAYA Biosciences (IDYA) over the last 8 years, with Dec 2024 value amounting to -$251.4 million.

  • IDEAYA Biosciences' Free Cash Flow rose 386.11% to $142.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.4 million, marking a year-over-year increase of 31.24%. This contributed to the annual value of -$251.4 million for FY2024, which is 113.82% down from last year.
  • As of FY2024, IDEAYA Biosciences' Free Cash Flow stood at -$251.4 million, which was down 113.82% from -$117.6 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Free Cash Flow registered a high of $54.9 million during FY2020, and its lowest value of -$251.4 million during FY2024.
  • Moreover, its 3-year median value for Free Cash Flow was -$117.6 million (2023), whereas its average is -$153.2 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 235.11% in 2020, then crashed by 206.33% in 2021.
  • Over the past 5 years, IDEAYA Biosciences' Free Cash Flow (Yearly) stood at $54.9 million in 2020, then plummeted by 206.33% to -$58.4 million in 2021, then slumped by 55.11% to -$90.6 million in 2022, then fell by 29.77% to -$117.6 million in 2023, then plummeted by 113.82% to -$251.4 million in 2024.